These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9215296)

  • 21. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular mechanisms of prostatic oncogenesis].
    Zezerov EG; Severin ES
    Vestn Ross Akad Med Nauk; 1998; (5):29-35. PubMed ID: 9662994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.
    Bonnet P; Reiter E; Bruyninx M; Sente B; Dombrowicz D; de Leval J; Closset J; Hennen G
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1203-8. PubMed ID: 7521342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation.
    Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
    Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
    Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of androgen metabolising enzymes in benign prostatic hyperplasia.
    Otpuschennikov AA; Khvostova EP; Krasilnikov CE; Gulyaeva LF
    Klin Lab Diagn; 2013 Oct; (10):52-4, 16-8. PubMed ID: 24640095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J; Hanchanale V; Foster CS; Javlé P
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone effect on the expression of genes that mediate testosterone metabolism and genes that mediate the effect of those metabolites on the prostate.
    Shidaifat F; Lin YC
    Life Sci; 2012 Sep; 91(5-6):194-8. PubMed ID: 22820544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens.
    Philip J; Ragavan N; Desouza J; Foster CS; Javlé P
    BJU Int; 2004 Jun; 93(9):1218-20. PubMed ID: 15180609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transrectal biopsy of the prostate: a review of 186 biopsies.
    Awojobi OA; Junaid TA; Nkposong EO
    Afr J Med Med Sci; 1983; 12(3-4):117-9. PubMed ID: 6202128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.
    Schostak M; Krause H; Miller K; Schrader M; Weikert S; Christoph F; Kempkensteffen C; Kollermann J
    BMC Urol; 2006 Mar; 6():7. PubMed ID: 16539730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.